Durão Raquel, Ramalhete Cátia, Madureira Ana Margarida, Mendes Eduarda, Duarte Noélia
Research Institute for Medicines (iMED.Ulisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal.
ATLANTICA-Instituto Universitário, Fábrica da Pólvora de Barcarena, 2730-036 Barcarena, Portugal.
Pharmaceuticals (Basel). 2022 Mar 10;15(3):340. doi: 10.3390/ph15030340.
Human African trypanosomiasis (sleeping sickness) and American trypanosomiasis (Chagas disease) are vector-borne neglected tropical diseases, caused by the protozoan parasites and , respectively. These diseases were circumscribed to South American and African countries in the past. However, human migration, military interventions, and climate changes have had an important effect on their worldwide propagation, particularly Chagas disease. Currently, the treatment of trypanosomiasis is not ideal, becoming a challenge in poor populations with limited resources. Exploring natural products from higher plants remains a valuable approach to find new hits and enlarge the pipeline of new drugs against protozoal human infections. This review covers the recent studies (2016-2021) on plant terpenoids, and their semi-synthetic derivatives, which have shown promising in vitro and in vivo activities against Trypanosoma parasites.
人类非洲锥虫病(昏睡病)和美洲锥虫病(恰加斯病)是由原生动物寄生虫分别引起的媒介传播被忽视热带病。过去,这些疾病局限于南美和非洲国家。然而,人类迁移、军事干预和气候变化对它们在全球的传播产生了重要影响,尤其是恰加斯病。目前,锥虫病的治疗并不理想,这对资源有限的贫困人口来说是一项挑战。探索高等植物中的天然产物仍然是寻找新的有效成分并扩大抗原生动物人类感染新药研发渠道的宝贵方法。本综述涵盖了近期(2016 - 2021年)关于植物萜类化合物及其半合成衍生物的研究,这些化合物在体外和体内对锥虫寄生虫均显示出有前景的活性。